Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab

Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study

Published:2012-01-18 Issue:5 Volume:57 Page:1341-1348
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Sorrentino Dario,Terrosu Giovanni,Paviotti Alberto,Geraci Marco,Avellini Claudio,Zoli Giorgio,Fries Walter,Danese Silvio,Occhipinti Pietro,Croatto Tiziano,Zarifi Dimitra

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-011-2025-z.pdf

Reference40 articles.

1. Sorrentino D, Terrosu G, Avellini C, et al. Prevention of postoperative recurrence of Crohn’s disease by infliximab. Eur J Gastroenterol Hepatol. 2006;18:457–459.

2. Sorrentino D, Terrosu G, Avellini A, et al. Infliximab and low dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn’s disease. Arch Intern Med. 2007;167:1804–1810.

3. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–450.

4. Sorrentino D, Paviotti A, Terrosu G, et al. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol. 2010;8:591–599.

5. Biancone L, Cretella M, Tosti C, et al. Local injection of infliximab in the postoperative recurrence of Crohn’s disease. Gastrointest Endosc. 2006;63:486–492.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic Assessment of Postoperative Recurrence in Crohn's Disease;Gastrointestinal Endoscopy Clinics of North America;2024-05

2. Predictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn’s Patients;Gastroenterology Research;2024-04

3. The long-term effect on surgery-free survival of biological compared to conventional therapy in Crohn’s disease in real world-data: a retrospective study;BMC Gastroenterology;2023-12-14

4. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn’s Disease Recurrence;Journal of Clinical Gastroenterology;2023-11-27

5. Infliximab for medical induction of remission in Crohn's disease;Cochrane Database of Systematic Reviews;2023-11-20